Treatment - NCI-CONNECTions
Rare brain and spine tumor treatment-related news and commentaries from patients and leading experts. Includes articles on treatment options, side effects, and treatment-related research.
-
A phase 1/2 clinical trial is testing an investigational drug called PLX038 on hard-to-treat central nervous system tumors containing extra copies of the MYC and MYCN genes.
-
A new trial investigates zotiraciclib as a treatment for people with recurrent gliomas containing an IDH1 or IDH2 mutation to control tumor growth and improve quality of life.
-
In a new systematic review, researchers identify the specific challenges that make it difficult for this patient population to enroll in clinical trials and seek specialized treatment.
-
Providers in the NCI-CONNECT Clinic collaborate with a patient’s local specialists to offer guidance and opportunities to participate in cutting-edge clinical trials.
-
Dr. Byram Ozer joins NCI-CONNECT to help care for and educate patients, while bringing together medical professionals to learn new skills and treatment approaches.
-
Neuroradiologist Dr. John Butman has advice for what to expect from brain and spinal cord imaging when you have a cancer diagnosis.
-
Neurosurgeon Dr. John Heiss shares how his ability to provide the best care for rare brain and spine tumor patients depends heavily on teamwork—both inside and outside the operating room.
-
Radiation Oncologist Dr. Kevin Camphausen is helping people with brain and spine tumors by developing drugs that can enhance the impact of radiation treatment.
-
Nick had four surgeries and multiple radiation treatments to address his ependymoma tumors. He shares what to expect during and after radiation—and how cancer changed his outlook on life.
-
Giselle shares her treatment journey with five brain tumors over 23 years. She gives important advice for managing chemotherapy and staying positive.